eFFECTOR Therapeutics Inc at Stifel Healthcare Conference Transcript
I think we'll go ahead and get started for the next session. Ben Burnett from Stifel. Pleased to have eFFECTOR Therapeutics with us today for a fireside chat. We have CFO, Mike Byrnes here; and CMO, Dr. Doug Warner. (technical difficulty) So we'll do a fireside chat for this one. (Conference Instructions)
But I think maybe just to kick it off, could you guys just maybe provide a brief overview of eFFECTOR, highlight near-term events that we should be focused on?
Sure. Absolutely. Thanks, Ben, and thanks to the Stifel team for hosting this conference again in person, which is great, back in New York City. So eFFECTOR was formed about 10 years ago, really to have a profound effect on blocking translation and profound effect in cancer.
So what we focused on specifically was one of the most mutated pathways in cancer, the RAS PI3K pathway. And instead of focusing on sort of the top end of that pathway, we focused on the bottom, which is the eIF4F complex
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
